Kellerer M - Search Results

1

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications.

Fritsche A, Heni M, Peter A, Gallwitz B, Kellerer M, Birkenfeld AL, Häring HU, Wagner R. Fritsche A, et al. Among authors: kellerer m. Exp Clin Endocrinol Diabetes. 2022 Mar;130(3):200-204. doi: 10.1055/a-1242-9809. Epub 2020 Sep 18. Exp Clin Endocrinol Diabetes. 2022. PMID: 32947641 Free PMC article.

2

Therapy of Type 2 Diabetes.

Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, Müller-Wieland D, Nauck MA, Wiesner T, Siegel E. Landgraf R, et al. Among authors: kellerer m. Exp Clin Endocrinol Diabetes. 2022 Sep;130(S 01):S80-S112. doi: 10.1055/a-1624-3449. Epub 2022 Jul 15. Exp Clin Endocrinol Diabetes. 2022. PMID: 35839797 Free article. No abstract available.

3

Therapy of Type 2 Diabetes.

Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, Müller-Wieland D, Nauck MA, Reuter HM, Siegel E. Landgraf R, et al. Among authors: kellerer m. Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S73-S92. doi: 10.1055/a-1018-9106. Epub 2019 Dec 20. Exp Clin Endocrinol Diabetes. 2019. PMID: 31860927 Free article. Review. No abstract available.

4

Insulin signal transduction: possible mechanisms for insulin resistance.

Kellerer M, Lammers R, Häring HU. Kellerer M, et al. Exp Clin Endocrinol Diabetes. 1999;107(2):97-106. doi: 10.1055/s-0029-1212082. Exp Clin Endocrinol Diabetes. 1999. PMID: 10320048 Review. No abstract available.

5

Insulin analogues: impact of cell model characteristics on results and conclusions regarding mitogenic properties.

Kellerer M, Häring HU. Kellerer M, et al. Exp Clin Endocrinol Diabetes. 2001;109(1):63-4. doi: 10.1055/s-2001-11022. Exp Clin Endocrinol Diabetes. 2001. PMID: 11573144 No abstract available.

6

Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells.

Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, Häring HU. Staiger H, et al. Among authors: kellerer m. Diabetes. 2004 Dec;53(12):3209-16. doi: 10.2337/diabetes.53.12.3209. Diabetes. 2004. PMID: 15561952

7

Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells.

Müller HK, Kellerer M, Ermel B, Mühlhöfer A, Obermaier-Kusser B, Vogt B, Häring HU. Müller HK, et al. Among authors: kellerer m. Diabetes. 1991 Nov;40(11):1440-8. doi: 10.2337/diab.40.11.1440. Diabetes. 1991. PMID: 1657668

8

Evidence for inhibition of leptin secretion by catecholamines in man.

Fritsche A, Wahl HG, Metzinger E, Renn W, Kellerer M, Häring H, Stumvoll M. Fritsche A, et al. Among authors: kellerer m. Exp Clin Endocrinol Diabetes. 1998;106(5):415-8. doi: 10.1055/s-0029-1212008. Exp Clin Endocrinol Diabetes. 1998. PMID: 9831308

9

Pathophysiology and pharmacological treatment of insulin resistance.

Matthaei S, Stumvoll M, Kellerer M, Häring HU. Matthaei S, et al. Among authors: kellerer m. Endocr Rev. 2000 Dec;21(6):585-618. doi: 10.1210/edrv.21.6.0413. Endocr Rev. 2000. PMID: 11133066 Review.

10

Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells.

Eitel K, Staiger H, Rieger J, Mischak H, Brandhorst H, Brendel MD, Bretzel RG, Häring HU, Kellerer M. Eitel K, et al. Among authors: kellerer m. Diabetes. 2003 Apr;52(4):991-7. doi: 10.2337/diabetes.52.4.991. Diabetes. 2003. PMID: 12663471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters